A detailed history of Brandywine Global Investment Management, LLC transactions in Biote Corp. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 91,497 shares of BTMD stock, worth $604,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,497
Previous 47,114 94.2%
Holding current value
$604,795
Previous $351,000 45.3%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.33 - $8.36 $236,561 - $371,041
44,383 Added 94.2%
91,497 $510,000
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $256,300 - $351,941
47,114 New
47,114 $351,000
Q4 2023

Feb 09, 2024

BUY
$4.43 - $5.81 $72,120 - $94,586
16,280 New
16,280 $80,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $50.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.